BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30333124)

  • 1. A Novel Platform for Cancer Vaccines: Antigen-Selective Delivery to Splenic Marginal Zone B Cells via Repeated Injections of PEGylated Liposomes.
    Shimizu T; Abu Lila AS; Kawaguchi Y; Shimazaki Y; Watanabe Y; Mima Y; Hashimoto Y; Okuhira K; Storm G; Ishima Y; Ishida T
    J Immunol; 2018 Nov; 201(10):2969-2976. PubMed ID: 30333124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoid follicle antigen (Ag) delivery and enhanced rodent humoral immune responses mediated by Ag-containing PEGylated liposomes.
    Shimizu T; Watanabe Y; Ando H; Ishima Y; Ishida T
    Vaccine; 2021 Feb; 39(7):1131-1139. PubMed ID: 33478792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells.
    Shimizu T; Mima Y; Hashimoto Y; Ukawa M; Ando H; Kiwada H; Ishida T
    Immunobiology; 2015 Oct; 220(10):1151-60. PubMed ID: 26095176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.
    Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S
    Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pH-sensitive fusogenic polymer-modified liposomes co-loaded with antigen and α-galactosylceramide as an anti-tumor vaccine.
    Okazaki S; Iwasaki T; Yuba E; Watarai S
    J Vet Med Sci; 2018 Feb; 80(2):197-204. PubMed ID: 29311431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation induced by PEG enhances humoral immune responses against antigens encapsulated in PEG-modified liposomes.
    Shimizu T; Awata M; Abu Lila AS; Yoshioka C; Kawaguchi Y; Ando H; Ishima Y; Ishida T
    J Control Release; 2021 Jan; 329():1046-1053. PubMed ID: 33080272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb.
    Ito D; Ogasawara K; Iwabuchi K; Inuyama Y; Onoé K
    J Immunol; 2000 Feb; 164(3):1230-5. PubMed ID: 10640735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Adjuvant Based on the Pore-Forming Protein Sticholysin II Encapsulated into Liposomes Effectively Enhances the Antigen-Specific CTL-Mediated Immune Response.
    Laborde RJ; Sanchez-Ferras O; Luzardo MC; Cruz-Leal Y; Fernández A; Mesa C; Oliver L; Canet L; Abreu-Butin L; Nogueira CV; Tejuca M; Pazos F; Álvarez C; Alonso ME; Longo-Maugéri IM; Starnbach MN; Higgins DE; Fernández LE; Lanio ME
    J Immunol; 2017 Apr; 198(7):2772-2784. PubMed ID: 28258198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
    Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
    Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-containing liposomes engrafted with flagellin-related peptides are effective vaccines that can induce potent antitumor immunity and immunotherapeutic effect.
    Faham A; Altin JG
    J Immunol; 2010 Aug; 185(3):1744-54. PubMed ID: 20610649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.
    Wakita D; Chamoto K; Zhang Y; Narita Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
    Int Immunol; 2006 Mar; 18(3):425-34. PubMed ID: 16415100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunity.
    Kojima N; Biao L; Nakayama T; Ishii M; Ikehara Y; Tsujimura K
    J Control Release; 2008 Jul; 129(1):26-32. PubMed ID: 18485512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon.
    Shimizu T; Ishida T; Kiwada H
    Immunobiology; 2013 May; 218(5):725-32. PubMed ID: 22995937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
    Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
    Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner.
    Ishida T; Wang X; Shimizu T; Nawata K; Kiwada H
    J Control Release; 2007 Oct; 122(3):349-55. PubMed ID: 17610982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ag-bearing liposomes engrafted with peptides that interact with CD11c/CD18 induce potent Ag-specific and antitumor immunity.
    Faham A; Altin JG
    Int J Cancer; 2011 Sep; 129(6):1391-403. PubMed ID: 21128234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: a model study.
    Zhou F; Rouse BT; Huang L
    Cancer Res; 1992 Nov; 52(22):6287-91. PubMed ID: 1384958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal Ag engrafted with peptides of sequence derived from HMGB1 induce potent Ag-specific and anti-tumour immunity.
    Faham A; Bennett D; Altin JG
    Vaccine; 2009 Sep; 27(42):5846-54. PubMed ID: 19660589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection.
    Mandal M; Lee KD
    Biochim Biophys Acta; 2002 Jun; 1563(1-2):7-17. PubMed ID: 12007619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.